Oncoinvent A

Oncoinvent A FCF per Share

The Free Cash Flow per Share of Oncoinvent A (ONCIN.OL) as of Nov 7, 2026 is -1.34 NOK. In the previous year, Free Cash Flow per Share was -1.68 NOK — a change of -20.08% (higher).

FCF per Share

-1.34NOK

YoY

-20.08%

Last updated:

Free Cash Flow per Share of Oncoinvent A is 2025 -1.34 NOK. Free Cash Flow per Share of Oncoinvent A was 2024 -1.68 NOK. It decreases by -20.08% higher compared to the previous year.

The Oncoinvent A FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
-3.49 NOK
Jan 1, 2019
-3.16 NOK
Jan 1, 2020
-0.36 NOK
Jan 1, 2021
-3.10 NOK
Jan 1, 2022
-2.99 NOK
Jan 1, 2023
-1.69 NOK
Jan 1, 2024
-1.68 NOK
Jan 1, 2025
-1.34 NOK
The Oncoinvent A FCF per Share history
YEARFCF per ShareYoY
-1.34NOK-20.08%
-1.68NOK-0.40%
-1.69NOK-43.55%
-2.99NOK-3.67%
-3.10NOK+764.74%
-0.36NOK-88.66%
-3.16NOK-9.35%
-3.49NOK-5.25%
-3.68NOK-8.07%
-4.01NOK+55.84%
-2.57NOK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Oncoinvent A Stock analysis

What does Oncoinvent A do? Oncoinvent ASA is a radiopharmaceutical company based in Oslo, Norway, operating within the Health Care sector. Listed on 13 December 2024, the firm employs 46 people and focuses on developing alpha-emitting radiotherapeutics for cancer patients. Its primary product, Radspherin, is an alpha-emitting radioactive microsphere therapy designed to treat metastatic cancers in body cavities. This suspension of calcium carbonate microspheres labelled with Radium-224 targets residual micro-metastases on intracavitary surfaces and in liquids after surgery, aiming to spare deeper organs from harmful radiation doses. Oncoinvent A is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Oncoinvent A stock

Free Cash Flow per Share of Oncoinvent A is -1.34 NOK in 2025.

Free Cash Flow per Share of Oncoinvent A changed from -1.68 NOK to -1.34 NOK, representing a -20.08% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Oncoinvent A since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Oncoinvent A

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Oncoinvent A